Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
By H. Karim-Kos, E. de Vries, Isabelle Soerjomataram, V. Lemmens, S. Siesling, J. Coebergh. European Journal of Cancer, 2008
808 citations recorded by the source corpus.
INTRODUCTION We present a comprehensive overview of most recent European trends in population-based incidence of, mortality from and relative survival for patients with cancer since the mid 1990s. METHODS Data on incidence, mortality and 5-year relative survival from the mid 1990s to early 2000 for the cancers of the oral cavity and pharynx, oesophagus, stomach, colorectum, pancreas, larynx, lung, skin melanoma, breast, cervix, corpus uteri, ovary, prostate, testis, kidney, bladder, and Hodgkin's disease were obtained from cancer registries from 21 European countries. Estimated annual percentages change in incidence and mortality were calculated. Survival trends were analyzed by calculating the relative difference in 5-year relative survival between 1990-1994 and 2000-2002 using data from EUROCARE-3 and -4. RESULTS Trends in incidence were generally favorable in the more prosperous countries from Northern and Western Europe, except for obesity related cancers. Whereas incidence of and mortality from tobacco-related cancers decreased for males in Northern, Western and Southern Europe, they increased for both sexes in Central Europe and for females nearly everywhere in Europe. Survival rates generally improved, mostly due to better access to specialized diagnostics, staging and treatment. Marked effects of organised or opportunistic screening became visible for breast, prostate and melanoma in the wealthier countries. Mortality trends were generally favourable, except for smoking related cancers. CONCLUSION Cancer prevention and management in Europe is moving in the right direction. Survival increased and mortality decreased through the combination of earlier detection, better access to care and improved treatment. Still, cancer prevention efforts have much to attain, especially in the domain of female smoking prevalence and the emerging obesity epidemic.
Subfields: Oncology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/6973d4c24265405e132fd3b6f454fb0d74b0a91c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Aben
- L. Kiemeney
- B. Ljungberg
- S. Campbell
- M. Ploeg
- D. Jacqmin
- J. E. Lee
- S. Weikert
Citations in the corpus
- The present and future burden of urinary bladder cancer in the world (2009, background): “[9] found a decline in UBC occurrence in most countries of Europe (with the exception of Central Europe) since mid 1990.”
- The epidemiology of renal cell carcinoma. (2011, background): “Although an increase in RCC has been observed globally during the last decades, in recent years RCC incidence is declining in some European countries, namely, Sweden, Poland, Finland, and the Netherlands [6].”